We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPYG icon
601
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.5B
$17M 0.02%
438,703
+11,367
+3% +$432K
HUM icon
602
Humana
HUM
$46.2B
$17M 0.02%
63,920
+19,741
+45% +$5.01M
GDV icon
603
Gabelli Dividend & Income Trust
GDV
$2.66B
$16.9M 0.02%
780,306
+276,891
+55% +$5.92M
PULS icon
604
PGIM Ultra Short Bond ETF
PULS
$18.3B
$16.9M 0.02%
336,573
+285,646
+561% +$14.3M
HSBC icon
605
HSBC
HSBC
$356B
$16.8M 0.02%
403,506
-47,383
-11% -$1.98M
PBA icon
606
Pembina Pipeline
PBA
$27.6B
$16.8M 0.02%
452,563
-3,784
-0.8% -$138K
KR icon
607
Kroger
KR
$34.8B
$16.8M 0.02%
773,071
+220,651
+40% +$5.37M
NDAQ icon
608
Nasdaq
NDAQ
$52.9B
$16.8M 0.02%
523,410
+1,971
+0.4% +$60.4K
TDY icon
609
Teledyne Technologies
TDY
$32B
$16.7M 0.02%
61,103
+96
+0.2% +$23.9K
BMRN icon
610
BioMarin Pharmaceuticals
BMRN
$12.4B
$16.7M 0.02%
194,791
+9,455
+5% +$809K
FDL icon
611
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.82B
$16.6M 0.02%
542,971
+20,417
+4% +$617K
OMFL icon
612
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
$4.87B
$16.6M 0.02%
559,620
-30,676
-5% -$895K
PH icon
613
Parker-Hannifin
PH
$135B
$16.6M 0.02%
97,595
-9,298
-9% -$1.6M
IEI icon
614
iShares 3-7 Year Treasury Bond ETF
IEI
$17.8B
$16.6M 0.02%
131,742
-37,047
-22% -$4.58M
ZBH icon
615
Zimmer Biomet
ZBH
$18.4B
$16.6M 0.02%
144,838
+27,061
+23% +$3.17M
IMCB icon
616
iShares Morningstar Mid-Cap ETF
IMCB
$1.7B
$16.5M 0.02%
339,896
+5,816
+2% +$278K
BHP icon
617
BHP
BHP
$230B
$16.4M 0.02%
317,338
-70,475
-18% -$3.4M
HEWJ icon
618
iShares Currency Hedged MSCI Japan ETF
HEWJ
$744M
$16.4M 0.02%
541,537
+31,574
+6% +$963K
THQ
619
abrdn Healthcare Opportunities Fund
THQ
$796M
$16.4M 0.02%
920,350
-3,035
-0.3% -$52.1K
KDP icon
620
Keurig Dr Pepper
KDP
$40.8B
$16.4M 0.02%
565,994
+6,572
+1% +$187K
EMB icon
621
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
$16.2M 0.02%
143,015
+19,466
+16% +$2.15M
IYJ icon
622
iShares US Industrials ETF
IYJ
$2.02B
$16.2M 0.02%
204,408
-25,298
-11% -$1.96M
EEMV icon
623
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.56B
$16.1M 0.02%
274,052
+97,085
+55% +$5.67M
IXUS icon
624
iShares Core MSCI Total International Stock ETF
IXUS
$60.1B
$16.1M 0.02%
273,742
+125,726
+85% +$7.33M
IUSG icon
625
iShares Core S&P US Growth ETF
IUSG
$33.7B
$16M 0.02%
255,244
+15,400
+6% +$947K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.